AskBio, Syndax and Catalyst All on the Fast Track

AskBio, Syndax and Catalyst All on the Fast Track

Submitted by admin on June 28, 2021 - 6:56pm
Source: 
BioSpace
News Tags: 
FDA
fast track status
AskBio
Bayer
gene therapy
LGMD
Syndax Pharma
leukemia
Catalyst Biosciences
episodic bleeding
Headline: 
AskBio, Syndax and Catalyst All on the Fast Track
snippet: 

The U.S. FDA granted Fast Track Designation to three biopharma companies for the treatment of LGMD, episodic bleeding and leukemia.

Do Not Allow Advertisers to Use My Personal information